Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.10.024
Abstract: INTRODUCTION The quadrivalent meningococcal conjugate vaccine MenACWY-CRM is recommended for 2-23 month-old infants/toddlers at increased risk for meningococcal disease. This study adds to the current knowledge of MenACWY-CRM safety among this age group in a clinical… read more here.
Keywords: infants toddlers; safety; quadrivalent meningococcal; vaccine ... See more keywords
Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
Sign Up to like & getrecommendations! Published in 2020 at "Microbial Genomics"
DOI: 10.1099/mgen.0.000486
Abstract: In 2010, Burkina Faso completed the first nationwide mass-vaccination campaign of a meningococcal A conjugate vaccine, drastically reducing the incidence of disease caused by serogroup A meningococci. Since then, other strains, such as those belonging… read more here.
Keywords: burkina faso; carriage isolates; conjugate vaccine; carriage ... See more keywords
Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Korean Medical Science"
DOI: 10.3346/jkms.2019.34.e169
Abstract: Background After the introduction of the meningococcal ACWY-CRM197 conjugate vaccine (MenACWY-CRM) in 2012 and the meningococcal ACWY-diphtheria toxoid conjugate vaccine (MenACWY-DT) in 2014, immunization was recommended for certain high-risk groups including new military recruits in… read more here.
Keywords: healthy adults; conjugate; comparison immune; diphtheria toxoid ... See more keywords
A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.814088
Abstract: The identification of an appropriate animal model for use in the development of meningococcal vaccines has been a challenge as humans are the only natural host for Neisseria meningitidis. Small animal models have been developed… read more here.
Keywords: immunogenicity; conjugate vaccines; mouse immunogenicity; model ... See more keywords